Cargando…
Intranasal insulin in Alzheimer’s disease: Food for thought
Accumulating evidence suggests that disrupted brain insulin signaling promotes the development and progression of Alzheimer’s disease (AD), driving clinicians to target this circuitry. While both traditional and more modern antidiabetics show promise in combating insulin resistance, intranasal insul...
Autores principales: | Chapman, Colin D., Schiöth, Helgi B., Grillo, Claudia A., Benedict, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523803/ https://www.ncbi.nlm.nih.gov/pubmed/29180222 http://dx.doi.org/10.1016/j.neuropharm.2017.11.037 |
Ejemplares similares
-
Intranasal Treatment of Central Nervous System Dysfunction in Humans
por: Chapman, Colin D., et al.
Publicado: (2012) -
Intranasal Insulin Enhances Postprandial Thermogenesis and Lowers Postprandial Serum Insulin Levels in Healthy Men
por: Benedict, Christian, et al.
Publicado: (2011) -
Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions
por: Schiöth, Helgi B., et al.
Publicado: (2011) -
Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
por: Freiherr, Jessica, et al.
Publicado: (2013) -
Experimenter gender and replicability in science
por: Chapman, Colin D., et al.
Publicado: (2018)